MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
606.32%
Quick Ratio
606.32%
Cash Ratio
240.84%
Debt to Asset Ratio
156.76%
Unit: Thousand (K) dollars
Assets Breakdown
    • Accounts receivable, net
    • Cash and cash equivalents
    • Deferred tax assets
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Revolving credit facility
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
79,127
220,471
215,456
140,407
Accounts receivable, net
112,732
105,842
46,745
120,370
Prepaid expenses and other current assets
7,342
5,979
11,977
13,066
Total current assets
199,201
332,292
274,178
273,843
Property and equipment, net
2,913
3,166
3,408
3,666
Operating lease right-of-use assets
8,443
8,896
9,340
9,775
Intangible assets, net
1,633
1,838
2,040
2,247
Deferred tax assets
69,064
84,237
103,433
101,687
Other assets
3,874
4,137
4,502
4,844
Total assets
285,128
434,566
396,901
396,062
Accounts payable
911
3,237
2,898
1,613
Accrued research and development costs
3,124
2,044
3,149
3,528
Accrued expenses and other current liabilities
25,534
27,903
33,239
34,620
Current portion of operating lease liabilities
3,285
3,268
3,252
3,236
Current portion of convertible senior notes
-
199,855
199,680
199,506
Total current liabilities
32,854
236,307
242,218
242,503
Operating lease obligations, net of current portion
8,581
9,233
9,870
10,498
Revolving credit facility
385,000
385,000
385,000
385,000
Other liabilities
20,536
21,170
21,648
22,218
Total liabilities
446,971
-
-
-
Class a common stock, 0.001 par value, 500,000,000 shares authorized 165,239,947 shares issued and outstanding as of june 30, 2026 and 163,058,316 shares issued and outstanding as of december 31, 2025
165
165
163
163
Additional paid-in capital
1,419,970
1,416,431
1,412,780
1,408,836
Accumulated deficit
-1,581,654
-1,632,945
-1,673,718
-1,671,442
Accumulated other comprehensive loss
-324
-795
-1,060
-1,714
Total stockholders' deficit
-161,843
-217,144
-261,835
-264,157
Total liabilities and stockholders' deficit
285,128
434,566
396,901
396,062
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Accounts receivable, net$112,732K (30.82%↑ Y/Y)Cash and cashequivalents$79,127K (-14.78%↓ Y/Y)Prepaid expenses andother current assets$7,342K (-42.32%↓ Y/Y)Total current assets$199,201K (3.88%↑ Y/Y)Deferred tax assets$69,064K (-46.65%↓ Y/Y)Operating leaseright-of-use assets$8,443K (-17.23%↓ Y/Y)Other assets$3,874K (-24.79%↓ Y/Y)Property and equipment,net$2,913K (-25.86%↓ Y/Y)Intangible assets, net$1,633K (-33.43%↓ Y/Y)Total assets$285,128K (-16.86%↓ Y/Y)Accumulated deficit-$1,581,654K (7.59%↑ Y/Y)Accumulated othercomprehensive loss-$324K (84.01%↑ Y/Y)Total liabilities andstockholders' deficit$285,128K (-16.86%↓ Y/Y)Total stockholders'deficit-$161,843K (47.48%↑ Y/Y)Additional paid-in capital$1,419,970K (1.05%↑ Y/Y)Class a common stock,0.001 par value,...$165K (1.85%↑ Y/Y)Total liabilities$446,971K Revolving credit facility$385,000K (0.00%↑ Y/Y)Total currentliabilities$32,854K (-85.87%↓ Y/Y)Other liabilities$20,536K (-8.59%↓ Y/Y)Operating leaseobligations, net of current...$8,581K (-22.81%↓ Y/Y)Accrued expenses andother current...$25,534K (6.25%↑ Y/Y)Current portion ofoperating lease...$3,285K (202.02%↑ Y/Y)Accrued research anddevelopment costs$3,124K (-31.36%↓ Y/Y)Accounts payable$911K (-34.41%↓ Y/Y)

IRONWOOD PHARMACEUTICALS INC (IRWD)

IRONWOOD PHARMACEUTICALS INC (IRWD)